Thermo Fisher’s Jennifer Cannon reviews the first year of the company’s Accelerator Drug Development suite of services and ...

3D printing technology enables precise drug design, personalized dosing, and versatile release modes, benefiting patient-centric treatments. At AAPS PharmSci 360, Xialing Li, PhD, says 3D-printed ...

Frank Romanski of Lonza Capsugel dives into the excipient side of manufacturing and the emerging prevalence of digitalization.

A streamlined workflow using Six Sigma's DMAIC methodology was developed to identify and mitigate visible particles in ...

Steve will be monitoring the Rapid Fires: AI/ML in Bioanalysis session on Monday, Nov. 10, 2025 at 3PM CT at AAPS PharmSci ...

In the life sciences industry, the journey from discovery to delivery is only as strong as the supply chain and distribution ...

To learn more about how method validation is performed for biomarker bioanalysis, Pharmaceutical Technology ® spoke with ...

Siddhant Sojitra, Alexion, defines in an AAPS PharmSci 360 2025 presentation an agitation model to reliably test stability for early-stage biologics.

Biopharma quality control is being revolutionized by advanced analytics and digital transformation through a synergy that boosts quality and scalability.

Discover how the targeted metabolomics screening workflow employing integrated SCIEX OS Software with the X500 QTOF System can benefit your lab. Get the essential updates shaping the future of pharma ...

Two major themes cut across the week’s news: the profound integration of advanced technology, particularly Artificial ...

Editor's note: this interview was originally published on BioPharmInternational.com.